Skip to main content
All lobbying filings

FIERCE GOVERNMENT RELATIONS

FIERCE GOVERNMENT RELATIONS filed a Q3 report for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA) on October 20, 2026, reporting $60,000 in lobbying income.

Lobbying for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA) · Trade Organization for Generic Drug Manufacturers and Distributers

All filings by FIERCE GOVERNMENT RELATIONS · Everything ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA) has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Pharmacy

Biosimilars; Generic drugs; Issues around country of origin labeling; Supply Chain; S.2658 - Medication Affordability and Patent Integrity Act; S.3014 - Ensuring Timely Access to Generics Act; S.1414 - Expedited Access to Biosimilars Act; S.1954 - Biosimilar Red Tape Reduction Act; S.3788 - Clear Labels Act; S.43 - Skinny Labels, Big Savings Act; Tariffs; General Business Issues.

 Bills named in this filing 6
  • S. 2658
    Medication Affordability and Patent Integrity Act
  • S. 3014
    Ensuring Timely Access to Generics Act of 2025
  • S. 1414
    Expedited Access to Biosimilars Act
  • S. 1954
    Biosimilar Red Tape Elimination Act
  • S. 3788
    CLEAR LABELS Act
  • S. 43
    Skinny Labels, Big Savings Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem